Arcus Biosciences RCUS Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's common stock, shares authorized (in shares)?
- Arcus Biosciences (RCUS) reported common stock, shares authorized (in shares) of $400M in Q1 2026.
- How has Arcus Biosciences's common stock, shares authorized (in shares) changed year-over-year?
- Arcus Biosciences's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $400M to $400M.
- What is the long-term trend for Arcus Biosciences's common stock, shares authorized (in shares)?
- Over 3 years (2022 to 2025), Arcus Biosciences's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $400M to $400M.